Regulated information

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2016

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2016

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

September 2016 year-to-date sales: €257.5 million a 4.8% organic growth

Vetoquinol posted sales of €257.5 million for the first nine months of 2016, up 2.3% compared to the same period last year. Organic growth for the period came to 4.8%, curbed by a 2.5% negative currency impact. 

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2016

as per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Vetoquinol launches its employer brand

The veterinary pharmaceutical company Vetoquinol launches its employer brand. For 83 years, Vetoquinol has been building its future, drawing on relationships of trust with its partners, the development of every employee, and its long-held belief of continuous improvement. Following on from its corporate brand, the company is now positioning itself as a high-quality employer.

Monthly information regarding the total number of voting rights and shares making of the share capital - August 2016

as per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Monthly information regarding the total number of voting rights and shares making of the share capital - July 2016

as per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Communiqué de mise à disposition du rapport financier semestriel relatif à l’exercice 2016 (french)

Communiqué de mise à disposition  du rapport financier semestriel relatif à l’exercice 2016 

Dynamic first half 2016

2016 Half year Financial Report

Monthly information regarding the total number of voting rights and shares making of the share capital - June 2016

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - May 2016

as per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - April 2016

as per article 223.16 of the « Règlement Général de L’Autorité des Marchés Financiers »

Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2015 (french version)

The Registration document of Vetoquinol relative to fiscal year 2015, including the Annual financial report relative to fiscal year 2014, was filed with the Autorité des marchés financiers (“the AMF”) on April 26, 2016.

Q1 sales: €85.8M

Vetoquinol posted Q1 2016 sales of €85.8 million, representing organic growth of 7.7%. Changes in exchange rates resulted in a negative currency impact of 2.1%; reported sales for the first three months of 2016 grew by 5.6%.

Monthly information regarding the total number of voting rights and shares making of the share capital - March 2016

As per article 223.16 of the « Règlement Général de L’Autorité des Marchés Financiers »

2015 results sales of reference products up 9.4% ebit up 10.3%

At its meeting on March 18, 2016, the Vetoquinol S.A. Board of Directors reviewed the Group’s results and approved the 2015 financial statements.

Monthly information regarding the total number of voting rights and shares making of the share capital - February 2016

as per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »

Monthly information regarding the total number of voting rights and shares making of the share capital - January 2016

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

2015 sales up 8.7% to €342.6 million

The Vetoquinol Group posted 2015 sales of €342.6 million, up 8.7% on reported data and up 3.8% at constant exchange rates. The Group benefited from a positive currency impact of 4.9% mainly linked to the US dollar, Indian rupee and British pound.

Monthly information regarding the total number of voting rights and shares making of the share capital - December 2015

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »